Novel results from our systems-level molecular profiling analysis include linking lineage (reflected by MITF expression), BRAF zygosity, cell-line specific mutations in proto-oncogenes and tumor suppressors and widespread transcriptional upregulation of ErbB family members and other receptor tyrosine kinases in the response and resistance of melanoma cells to PLX4720. This evidence concerns the gene BRAF and melanoma.